Contact us

(886)-2-82192005

Who we are

WS Far IR Medical Technology Co., Ltd. is founded in 1991 and has been the pioneer in FIR industry worldwide. Our product WS Far Infrared Therapy Unit (TY-101N) is used in clinical researches, as well as for treatment in a variety of clinical specialties. TY-101N features innovative patented structure that was designed with patients’ need in mind; not only is it simple to assemble and operate, but also facilitates exceptional therapeutic effect with minimal effort. As a result of our dedicated pursuit of professional knowledge and continuing product enhancement, we have won praises and approval from renowned doctors and numerous patients in Taiwan, and have attracted international researchers’ attention. We’re seeking regional distributors in European countries.

Milestones

  • January

    The newly publications which used FIRAPY to investigate it’s effect on nerves repairmen. The title of the paper is “Far-Infrared Therapy Promotes Nerve Repair following End-to-End Neurorrhaphy in Rat Models of Sciatic Nerve Injury” and published in Evidence-Based Complementary and Alternative Medicin.

  • April

    We attended the 9th Vascular Access Society (VAS) at Barcelona, Spanish.

  • May

    We attended 52nd European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) in the UK.

    In the conference, we show the results of scientific study of our product on hemodialysis. The effectiveness of Firapy attract attendees’ attention.

  • June

    The 60th Japanese Society for Dialysis Therapy (JSDT) was held in Yokohama, Japan. This is the first time we use the new brand name “Firapy” to exhibit. It’s also as a notification that our device will be listed in Japan.

  • August

    The three-day Dialysis Access Symposium (DAS) was held at the Conference Center of Grand Walkerhill in Seoul, South Korea. In particular, two physicians from Taiwan who apply Firapy on fistula very well were invited to share their experience of Firapy.

  • September

    ● Our device was exhibited on Japanese Society of Dialysis Access (JSDA) in Hiroshima, Japan.

    ● The 9th International Congress of the International Society for Hemodialysis (ISHD) was held in Kuala Lumpur, Malaysia this year. There are three Malaysian physicians share their preliminary result of the clinical trials of Firapy.

2015 9th VAS Congress
2015 Annual meeting of ERA-EDTA
The presentation @ DAS
  • May

    ● We were invited to participate and exhibit our product in the 14th Asian Pacific Society of Nephrology (APCN) by the president, professor Yasuhiko Tomino. This is also our first time to show our product in Japan.
    ● The new model, KP-B210, is specifically designed for the hemodialysis patients. This model is smaller, desktop, and the irradiation area can completely cover fistula. It’s applicable to the forearm or upper arm and easy apply for taking care fistula at home by the patient themselves. We look forward that this model can completely improve the healthcare of vascular access.

  • June

    ● We participated in the 51st European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) in Netherlands. Our new model, KP-B210, a new model specifically designed for the kidneys is also making its debut in Europe.

    ● We attended the 59th Japanese Society for Dialysis Therapy (JSDT) in Kobe, Japan.

  • August

    Khalid Bashar, a British vascular surgeon, has reviewed and analyzed the results of several far-infrared related papers, and the analysis result is published in the PloS One. In this study, it also reconfirms the effectiveness of Firapy in the fistula.

  • September

    A newly publication “Far-infrared Therapy as a Novel Treatment for Encapsulating Peritoneal Sclerosis” was published on The American Journal of GASTROENTEROLOGY.

  • October

    We start to cooperate with Malaysian distributor, AIM MEDICAL SUPPLIES.

2014 Annual meeting of ERA-EDTA
2014 Annual meeting of JSDT
AIM MEDICAL SUPPLIES
  • January

    The study “Length polymorphisms of heme oxygenase-1 determine the effect of far-infrared therapy on the function of arteriovenous fistula in hemodialysis patients: a novel physicogenomic study” was published in Nephrology Dialysis Transplantation. This study shows that dialysis patients with specific constitution have a better response to far-infrared radiation therapy.

  • April

    We met with the Research Team of the University of Cincinnati who focus on dialysis vascular access and discussed the feasibility of Firapyin to do the clinical trial in the United States.

  • May

    We participated in the Annual Meeting of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) and World Congress of Nephrology (WCN) in May. We used the slogan “Fistula First, Maturation First – Effective Solution of Vascular Access Problem" to show the effectiveness of Firapy on AVF maturation.

  • August

    The clinical and basic study which was cooperation between WS and Nephrology department of Taipei Veterans General Hospital was published in American Journal of Kidney Diseases (AJKD). The title is “Effect of Far Infrared Therapy on Arteriovenous Fistula Maturation: An Open-Label Randomized Controlled Trial”. This study provides clear scientific evidence for the use of far-infrared to improve the fistula maturation.

  • September

    Newly publication: “Effects of far-infrared radiation on heart rate variability and central manifestations in healthy subjects” was published in Journal of Lasers in Medical Sciences.

  • October

    WS is going to Italy!

    The Italian company, DIALMEDICA, visited us on October 21-25 for talking about sole distribution. Happily, we get a new partner in Europe.

2013 ERA-EDTA
2013 ERA-EDTA
2013 WCN
  • February

    Miss R. T. Wong, the assist manager of sales in the company become Secretary General of Taiwan Association for Dialysis Patients’ Quality of Life.

  • March

    ● Attend and exhibit in Congress of Taiwan Wound, Ostomy and Continence Nurses Association (TWOCNA).

    ● Attend and exhibit in Congress of Taiwan Surgical Association

    ● Far-infrared Therapy is elected as National Research Program of Biopharmaceutical (NRPB).

    ● WS Far-infrared Therapy unit successfully registered in China. News Links

  • April

    Visit the 65th China International Medical Equipment Fair at Shenzhen, China.

  • May

    Attend and exhibit 49th Congress ERA-EDTA in Paris, France.

  • June

    Attend and exhibit in 2012 SenCare. A new study of clinical application and mechanism of Far-infrared is open in the event. It is produced by Natiaonal Yang-Ming University, School of Medicine, Institute of Traditional Medicine.

  • September

    ● Sponsor the event of lecture of “Far-infrared medical care applications”, which is held by Taiwan Association for Dialysis Patients’ Quality of Life in Chiayi.

    ● Attend and exhibit in 2012 Asian Nephrology Nursing Symposium, as the focus of attendees.

  • October

    Attend and exhibit in Annual Congress of Chinese Society of Nephrology 2012, which is held in Chengdu, China.

  • November

    ● Sponsor the event of lecture of “Far-infrared medical care applications”, which is held by Taiwan Association for Dialysis Patients’ Quality of Life in Hualien.

    ● Invited to introduce the benefit mechanism of Far-infrared in wound care in “Taiwan wound and ostomy nurse training course”, by Taiwan Wound, Ostomy and Continence Nurses Association (TWOCNA).

  • December

    ● Attend and exhibit in 2012 Taiwan Society of Nephrology.

    ● Sponsor the event of lecture of “Build and maintenance of HD access”, which is held by Taiwan Association for Dialysis Patients’ Quality of Life in Tainan.

    ● Invited to present “total solution of vascular access problem” in” Anhui 2012 blood purification salon”.

2012 ERA-EDTA
2012 ANNS
Presentation at 2012 Anhui blood purification salon
  • March

    ● Attend and exhibit in Annual congress of Taiwan Society of Surgery. A new subject of “Far-infrared promotes Angiogenesis in ischemia tissue” was raised.

    ● Attend and exhibit in Taiwan Society of Obstetrics and Gynecology.

  • June

    ● Attend and exhibit in 2011 SenCare, a New model of TY-301R with 2 colors formally appear on the market.

    ● Invited to attend 2011 British Renal Society by UK distributor, Stanningley Pharma. News Link

  • November

    ● Attend and exhibit in Kidney Week 2011, in Philadelphia, US.

    ● Attend and exhibit in Annual Congress of Taiwan Medical Association.

    ● Attend and exhibit in Taiwan Nursing Home Association 2011.

  • December

    Attend and exhibit in Taiwan Society of Nephrology.

2011 British Renal Society
2011 Kidney Week
2011 Taiwan Society of Nephrology
  • March

    ● Attend and exhibit in Annual congress of Taiwan Society of Surgery.

    ● Attend and exhibit in Taipei International Symposium on Traditional Chinese Medicine and Traditional Chinese Medicine Exhibition

  • May

    Attend and exhibit in Annual meeting of Taiwan Academy of Physical Medicine and Rehabilitation.

  • June

    Attend 1st Taiwan International Medical & Healthcare Exhibition.

  • October

    A new study cooperate and produced with Kaohsiung Chang Gung Memorial Hospital published on Photochemistry and Photobiology:

    Far-Infrared Radiation Promotes Angiogenesis in Human Microvascular Endothelial Cells via Extracellular Signal-Regulated Kinases Activation

  • November

    Attend and exhibit in 22nd Taipei International medical and healthcare exhibition.

  • December

    ● Attend and exhibit in Taiwan Society of Nephrology.

    ● Participate in movement of “Act for preventing fistula dysfunction”, which is Initiated by National Kidney Foundation, Taoyuan Kidney Patients’ Association, and Keelung Kidney Patients’ Association.

2010 Annual congress of Taiwan Society of Surgery
  • May

    Attend and exhibit in ERA-EDTA and WCN.

  • August

    ● Co-organized “Continuing education courses of dialysis nurses”, hosted by Taipei City Hospital.

    ● Co-organized “Continuing education courses of dialysis nurses”, hosted by Tungs’ Taichung Metroharbor Hospital.

  • October

    Attend and exhibit in 2009 Kidney Week exhibition.

  • November

    Attend and exhibit in 2009 Mediphar Taipei, WS Far-infrared Therapy unit is elected as Innovative Product Award

  • December

    ● Attend and exhibit in Taiwan Society of Nephrology.

  • April

    “Far Infrared Therapy Inhibits Vascular Endothelial Inflammation via the Induction of Heme Oxygenase-1” by Dr. CC Lin was published in the April issue of Arteriosclerosis, Thrombosis, Vascular Biology.

  • May

    ● Exhibited at the annual meeting of European Renal Association – European Dialysis and Transplant Association in Stockholm, Sweden.

    ● Exhibited at the annual meeting of British Renal Society in Glasgow, UK.

  • August

    Received FDA pre-market approval (K080465)

2008 Annual meeting of ERA-EDTA
2008 Annual meeting of BRS
  • March

    “Far-Infrared Therapy: A Novel Treatment to Improve Access Blood Flow and Unassisted Patency of Arteriovenous Fistula in Hemodialysis Patients” by Dr. CC Lin was published in the March issue of Journal of American Society of Nephrology.

  • June

    ● TY-101N/102N, TY-301R/302R obtained CE 0434 certification.

    ● US FDA 510(k) for TY-101N pending.

    ● Exhibited at the annual meeting of European Renal Association – European Dialysis and Transplant Association in Barcelona, Spain for the first time.

  • August

    Exhibited at the Annual Meeting of Nephrology Society of Thailand in Cha-Am, Thailand.

  • November

    Exhibited at the Renal Week of American Society of Nephrology in San Francisco, USA

2007 Annual meeting for ERA-EDTA
2007 Annual meeting of NST
2007 Renal Week of ASN
  • January

    “WS Far Infrared Therapy Unit" Multi-function TY-101N was officially released and the former TY-101 was off production.

  • October

    TY-101N obtained ISO9001 authentication.

  • November

    ● Successively exhibited at the MEDIPHAR TAIPEI 2006.

    ● Exhibited at the Annual Meeting of ASN (the American Society of Nephrology) for the first time.

2006 MEDIPHAR TAIPEI
2006 MEDIPHAR TAIPEI
  • January

    ● “WS Far Infrared Therapy Unit" TY-101 officially obtained the Medical Device License issued by Department of Health.

    ● Dr. S.Y. Yu conducted animal experiment in “Far Infrared Treatment to Promote Skin Micro-circulation".

  • March

    ● Exhibited at the Annual Meeting of Taiwan Surgical Association for the first time.

    ● “WS Far Infrared Therapy Unit" Three-purpose TY-301 was officially released.

    ● Dr. C.C. Lin undertook clinical experiments “The Effect of Far Infrared Therapy on the Access Blood Flow and Unassisted Patency of Arteriovenous Fistula in Hemodialysis Patients".

    ● “WS Far Infrared Therapy Unit" Medically Dedicated TY-601 was released.

    ● TY-101N was patented in Taiwan “WS Far Infrared Therapy Unit".

  • October

    Also applied in care for urology surgical diseases by Shu-tien Clinic.

     

  • October-December

    ● Successively exhibited at Taipei Medical Beauty Expo, Taipei.

    ● International Show on Medical Equipment & Pharmaceuticals and the Annual Meeting for Taiwan Society of Nephrology.

  • December

    ● Organized by Far Infrared Healthcare Association and assisted by WS Far IR Medical Technology, the “Experience Exchange Seminar on Medical Application of Far Infrared " was held in Taichung Splendor Hotel, presented by Dr. R.C. Chiang and participated by doctors and nurses from hemodialysis divisions.

    ● “WS Far Infrared Therapy Unit" TY-101 was patented in Taiwan.

2005 Annal meeting for Taiwan Association of Nephrology
  • March-July

    ● We were appraised as the manufacturer who meets Good Manufacturing Practice (GMP) for medical devices manufacturers by Department of Health, Executive Yuan. Be the first professional manufacturer of Far Infrared therapeutic apparatus who meets GMP standard in Taiwan .

    ● Assisted by Hi-Clearance INC., WS Far IR Medical Technology sponsored the “Clinical Service for Nepro-patients’ Fistulas and Lecture on Far Infrared Health Care" in March.

    ● In July, we sponsored the “Experience Exchange Seminar on Medical Application of Far Infrared " in Kaohsiung Ambassador Hotel and Tainan La Plaza Hotel, which was presented by Doctor RC Chiang and participated by doctors and nurses from hemodialysis divisions.

  • July

    Applied in post-operative care in Vascular Surgical Wards of Taipei Wanfang Hospital.

  • November

    Sponsored by Taipei Wanfang Hospital and assisted by Association of Diabetes Educators and WS Far IR Medical Technology, a lecture on “How to Avoid Diabetic Amputation"  was given by Doctor YJ Chang in Wanfang Hospital, in which he mentioned how to make effective use of Far Infrared as an adjunctive therapy.

2004 Taipei International Show on Medical Equipment & harmaceuticals
2004 Taipei International Show on Medical Equipment & Pharmaceuticals

  • Exhibited at the Annual Meeting for Taiwan Association of Nephrology, Annual Meeting for Taiwan Academy of Physical Medicine and Rehabilitation and Taipei International Show on Medical Equipment & Pharmaceuticals.

2002 Annal meeting for Taiwan Association of Nephrology

  • ● Co-sponsored the「 Symposium on Basic and Clinical Application of Far Infrared」together with the Electric Machine Department of National Cheng Kung University and Far Infrared Healthcare Association , at which Professor BJ Wu from Biophysics Department of Medical Division in Peking University, Professor MS Yang from National Cheng Kung University, Doctor RC Chiang from Show Chwan Memorial Hospital and Doctor SH Wang (Director of Submarine Medicine Department of Keelung Armed Forces Hospital) were invited to attend. It was held three times respectively in Taipei , Taichung and Tainan in March and caused a great social sensation.

    ● Developed 「 WS Far Infrared Fiber Blanket」

2001 Symposium on Basic and Clinical Application of Far Infrared
2001 Symposium on Basic and Clinical Application of Far Infrared

  • Applied by Hyperbaric oxygen Center (Submarine Medicine Department) in wound healing.


  • Applied successively by all hemodialysis divisions throughout Taiwan.Far Infrared Healthcare Association was officially approved for establishment.


  • ● Doctor RC Chiang, Director of Cardiovascular Surgery Department of Show Chwan Memorial Hospital, started the clinical research of fistula exposed in Far Infrared. Far Infrared Healthcare Association was sketched.

    ● “WS Far Infrared Therapy Unit" TY-101 was patented in Mainland China.


  • ● Applied by TCM (Traditional Chinese Medicine) Department of Chang Gung Memorial Hospital ( Medical Center ) and chain rehabilitation clinics affiliated with SST Company, marking its entrance into the medical field of rehabilitation; also exhibited at the Taipei International Show on Medical Equipment & Pharmaceuticals.

    ● “WS Far Infrared Therapy Unit"  TY-101 was patented in Japan.


  • ●  “WS Far Infrared Therapy Unit"  TY-101 was patented in Taiwan.


  • ● Applied by TCM (Traditional Chinese Medicine) Department of Tzu Chi Hospital, marking the beginning of TCM circle’s paying great attention to application of far infrared.


  • ● WS Far IR Medical Technology Co., Ltd. was founded.

    ● WS Far Infrared Therapy Unit TY-101 was released.